Medical journal The Lancet has announced the relaunch of its online medical journals at http://www.TheLancet.com. Owned by STM publisher Elsevier, TheLancet.com is projected as the company's latest solution for delivering flagship medical journal content in daily, contextualised updates for the clinical community.
TheLancet.com has been completely rebuilt in a bid to provide a smooth and speedy online environment for busy clinicians to access the latest medical evidence. The site seeks to provide three unique benefits for busy hospital clinicians and medical researchers. This includes quick and easy access to daily online first research published across Lancet journals (The Lancet, The Lancet Infectious Diseases, The Lancet Neurology and The Lancet Oncology); free access to exclusive online-only editorial analysis of how the most important published research impacts practice; and specialty-specific article collections from across Lancet journals, providing immediately relevant updates for specialists. The last will be launched over the coming months.
Incorporating input from 100 medical students, clinicians, senior consultants, medical researchers and academics from all over the world, TheLancet.com is built with web technologies such as J2EE, Spring, Ajax and MarkLogic XML database functionality. The site, projected as a fast and intuitive interactive online resource, has been developed using Agile processes to produce a lean and efficient portal.
Other site features that add value to core journal content include Editor's Choices for each journal, additional editorial analysis, 'This Week in Medicine' news, video in collaboration with Global Health TV, and weekly podcasts. Additional online community features planned for the site include social networking, debates, Wikis and discussion boards. Article Collections in core therapeutic areas from across all Lancet journals will be launched in the coming months.
